Abstract
Uses for relatively new biologic therapies approved for other conditions, such as rheumatoid arthritis, are now emerging for the treatment of moderate or severe chronic plaque psoriasis and psoriatic arthritis.
| Original language | English |
|---|---|
| Pages (from-to) | 46-50 |
| Number of pages | 5 |
| Journal | Patient Care |
| Volume | 38 |
| Issue number | 12 |
| State | Published - Dec 2004 |